Annotation Detail

Information
Associated Genes
KRAS
Associated Variants
KRAS MUTATION
KRAS MUTATION
Associated Disease
lung adenocarcinoma
Source Database
CIViC Evidence
Description
In a study of 1036 patients with lung adenocarcinoma, patients with KRAS mutations (n=241) showed worse prognosis (OS: 19 months versus 23 months; HR=1.21; P=0.048).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1700
Gene URL
https://civic.genome.wustl.edu/links/genes/30
Variant URL
https://civic.genome.wustl.edu/links/variants/336
Rating
4
Evidence Type
Prognostic
Disease
Lung Adenocarcinoma
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
22810899
Drugs